Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Preprint |
| Published: |
2024
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2401.17157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866913215923879936 |
|---|---|
| author | Sonzogni, Beatrice Manzano, José María Polver, Marco Previdi, Fabio Ferramosca, Antonio |
| author_facet | Sonzogni, Beatrice Manzano, José María Polver, Marco Previdi, Fabio Ferramosca, Antonio |
| contents | This work presents a Model Predictive Control (MPC) for the artificial pancreas, which is able to autonomously manage basal insulin injections in type 1 diabetic patients. Specifically, the MPC goal is to maintain the patients' blood glucose level inside the safe range of 70-180 mg/dL, acting on the insulin amount and respecting all the imposed constraints, taking into consideration also the Insulin On Board (IOB), to avoid excess of insulin infusion. MPC uses a model to make predictions of the system behaviour. In this work, due to the complexity of the diabetes disease that complicates the identification of a general physiological model, a data-driven learning method is employed instead. The Componentwise Hölder Kinky Inference (CHoKI) method is adopted, to have a customized controller for each patient. For the data collection phase and also to test the proposed controller, the virtual patients of the FDA-accepted UVA/Padova simulator are exploited. The proposed MPC is also tested on a modified version of the simulator, that takes into consideration also the variability of the insulin sensitivity. The final results are satisfying since the proposed controller reduces the time in hypoglycemia (which is more dangerous) if compared to the outcome obtained with the standard constant basal insulin therapy provided by the simulator, satisfying also the time in range requirements and avoiding long-term hyperglycemia events. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2401_17157 |
| institution | arXiv |
| publishDate | 2024 |
| record_format | arxiv |
| spellingShingle | CHoKI-based MPC for blood glucose regulation in Artificial Pancreas Sonzogni, Beatrice Manzano, José María Polver, Marco Previdi, Fabio Ferramosca, Antonio Systems and Control This work presents a Model Predictive Control (MPC) for the artificial pancreas, which is able to autonomously manage basal insulin injections in type 1 diabetic patients. Specifically, the MPC goal is to maintain the patients' blood glucose level inside the safe range of 70-180 mg/dL, acting on the insulin amount and respecting all the imposed constraints, taking into consideration also the Insulin On Board (IOB), to avoid excess of insulin infusion. MPC uses a model to make predictions of the system behaviour. In this work, due to the complexity of the diabetes disease that complicates the identification of a general physiological model, a data-driven learning method is employed instead. The Componentwise Hölder Kinky Inference (CHoKI) method is adopted, to have a customized controller for each patient. For the data collection phase and also to test the proposed controller, the virtual patients of the FDA-accepted UVA/Padova simulator are exploited. The proposed MPC is also tested on a modified version of the simulator, that takes into consideration also the variability of the insulin sensitivity. The final results are satisfying since the proposed controller reduces the time in hypoglycemia (which is more dangerous) if compared to the outcome obtained with the standard constant basal insulin therapy provided by the simulator, satisfying also the time in range requirements and avoiding long-term hyperglycemia events. |
| title | CHoKI-based MPC for blood glucose regulation in Artificial Pancreas |
| topic | Systems and Control |
| url | https://arxiv.org/abs/2401.17157 |